You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on CypComp Database.
Record Information
Version1.0
Creation Date2019-07-14 16:53:24 UTC
Last Updated2019-10-01 21:41:55 UTC
CypComp IDCC02348
Compound Information
NameMK-0767
Structure ImageRxrulmgjksldfm inizcteosa n
InChIKeyRXRULMGJKSLDFM-INIZCTEOSA-N
PubChem ID87173364
CypCompound Information
SetCypBoM Training Set
Bonds of Metabolism (BoMs)
CYP1A2CYP2A6CYP2B6CYP2C8CYP2C9CYP2C19CYP2D6CYP2E1CYP3A4
  • Not Available
  • Not Available
  • Not Available
  • Not Available
  • Not Available
  • Not Available
  • Not Available
  • Not Available
  • <24,H;Hydroxylation;R1>
  • <25,S;S-Oxidation;R2>
References
  1. Liu DQ, Karanam BV, Doss GA, Sidler RR, Vincent SH, Hop CE: In vitro metabolism of MK-0767 [(+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl)-ph enyl] methyl]benzamide], a peroxisome proliferator-activated receptor alpha/gamma agonist. II. Identification of metabolites by liquid chromatography-tandem mass spectrometry. Drug Metab Dispos. 2004 Sep;32(9):1023-31. doi: 10.1124/dmd.104.000059. [PubMed:15319345 ]
Download FileCC02348.sdf